Julie Dietrich has held VP and Director positions in biopharma sponsor companies, covering clinical program strategy, design, planning, and implementation. Julie has led cross-functional strategic and process improvement initiatives involving incorporation of innovative technologies, including for patient engagement, clinical outcome assessments / patient reported outcomes data collection, evidence generation planning, and pipeline optimization.
.Speaker Group: DTCT US 2024- Speakers
Meghann Dryer
Meg Dryer is the General Manager of Consumer at Evidation, where she is responsible for Evidation’s presence in the market. Prior to Evidation, Meg was VP of Consumer Experience at Cambia Health Solutions. Before moving into healthcare, Meg led teams at Nike where she worked on projects such as the Rio Olympics and at IDEO,… Read more »
Srinivas Kommalapati
Srinivas Kommalapati, CEO of Mushroom Solutions Inc, brings over 25 years of experience in the software industry, specializing in AI/ML, Big Data, Automation, and Product & Application Engineering. A BITS Pilani graduate in Pharmacy, Srinivas has spent over two decades in the Bay Area, immersing himself in Silicon Valley’s innovative culture. Under his leadership, Mushroom… Read more »
Wessam Sonbol
Dana Immerso
As the Director of Strategic Partnerships for Avrok Biosciences, Dana Immerso combines her expertise in patient recruitment and engagement with her role in forging collaborative alliances. Her leadership within Avrok Biosciences underscores her commitment to driving innovation in discovery research and clinical trials while prioritizing patient-centricity. Drawing from her background as a rare disease patient… Read more »
Miles Alexander Welbourn
Miles Welbourn is a biomedical engineer by training, and he is an expert in biomechanics and wearable biosensors. He works as the technical lead for the Pfizer Innovation Research Lab in Cambridge, MA as part of a multidisciplinary team often comprised of clinicians, research scientists, data scientists, and engineers to develop and validate precise and… Read more »
Bob Bois
Hao Zhang
Dr. Hao Zhang is currently the Director, Digital Healthcare Innovation at Mitsubishi Tanabe Pharma America, Inc. Previously he was an Associate Director/Senior Manager in Pfizer Inc, in the Digital Medicine group. He has been working on evaluating, developing, validating and implementing new digital health technologies and digital endpoints in clinical trials and for clinical care. Prior to his digital medicine… Read more »